Cargando…

Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures

Mostrar otras versiones (1)

The longstanding paradigm is that most bloodstream infections (BSIs) are caused by a single organism. We performed whole genome sequencing of five-to-ten strains from blood culture (BC) bottles in each of ten patients with Candida glabrata BSI. We demonstrated that BCs contained mixed populations of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badrane, Hassan, Cheng, Shaoji, Dupont, Christopher L, Hao, Binghua, Driscoll, Eileen, Morder, Kristin, Liu, Guojun, Newbrough, Anthony, Fleres, Giuseppe, Kaul, Drishti, Espinoza, Josh L, Clancy, Cornelius J, Nguyen, M. Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104189/ https://www.ncbi.nlm.nih.gov/pubmed/37066226 http://dx.doi.org/10.21203/rs.3.rs-2706400/v1

Ejemplares similares

Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures
por: Badrane, Hassan, et al.
Publicado: (2023)

116. Characterization of small colony variants from a patient with bloodstream infection of Candida glabrata
por: Cheng, Shaoji, et al.
Publicado: (2021)

215. Candida glabrata (CG) Bloodstream Infections (BSIs) Are Characterized by Genetically Diverse Populations of Strain Variants Recovered from Positive Blood Cultures (BCs)
por: Hassan, Badrane, et al.
Publicado: (2021)

Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia
por: Cheng, Shaoji, et al.
Publicado: (2022)

Candida albicans Transcriptional Profiling Within Biliary Fluid From a Patient With Cholangitis, Before and After Antifungal Treatment and Surgical Drainage
por: Clancy, Cornelius J., et al.
Publicado: (2016)

1422. Surveillance for fungi in hospital environments housing high-risk hosts using culture and culture-independent methods
por: Clancy, Cornelius J, et al.
Publicado: (2023)

Biguanides enhance antifungal activity against Candida glabrata
por: Xu, Shuying, et al.
Publicado: (2018)

Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015)

Effect of Antifungal-Treated Host Macrophages on Candida glabrata
por: Li, Hong-Bin, et al.
Publicado: (2021)

Catechin potentiates the antifungal effect of miconazole in Candida glabrata
por: Hervay, Nora Tóth, et al.
Publicado: (2023)

1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin Resistance
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
por: Andersen, Kari-Mette, et al.
Publicado: (2016)

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata
por: Ito, Yuya, et al.
Publicado: (2020)

Evaluation of antifungal susceptibility in clinical isolates of the Candida glabrata complex
por: Jesus, Filipa, et al.
Publicado: (2021)

Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
por: Martínez-Herrera, Erick, et al.
Publicado: (2021)

420. A Rapid PCR Assay Detects Fungemia Due to Mixed Candida Species That Is Missed by the Clinical Microbiology Laboratory
por: Clancy, Cornelius J, et al.
Publicado: (2018)

Genetic diversity of clinical and environmental Mucorales isolates obtained from an investigation of mucormycosis cases among solid organ transplant recipients
por: Nguyen, M. Hong, et al.
Publicado: (2020)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
por: Tscherner, Michael, et al.
Publicado: (2011)

Multi-route antifungal administration in the management of urinary Candida glabrata bezoar
por: Viswambaram, Pravin, et al.
Publicado: (2020)

1727. Candida albicans Phosphatidylinositol-(4,5)-Bisphosphate (PIP2) Directs Aberrant Cytokinesis and Septation in Response to Echinocandins, Which Correlates with Fungicidal Activity and Attenuated Virulence
por: Badrane, Hassan, et al.
Publicado: (2019)

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis
por: Kiasat, Neda, et al.
Publicado: (2019)

The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata
por: Rodrigues, Célia F., et al.
Publicado: (2018)

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata
por: Minematsu, Asuka, et al.
Publicado: (2019)

Evaluation of antifungal activity of mint, pomegranate and coriander on fluconazole-resistant Candida glabrata
por: Jayan, Lekshmy, et al.
Publicado: (2020)

Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2021)

Exhibition of antifungal resistance by sterol-auxotrophic strains of Candida glabrata with intact virulence
por: Nagi, Minoru, et al.
Publicado: (2022)

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
por: Fatahinia, Mahnaz, et al.
Publicado: (2020)

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata
por: Gamal, Ahmed, et al.
Publicado: (2021)

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
por: Nagayoshi, Yohsuke, et al.
Publicado: (2017)

383. An Increased Rate of Candida parapsilosis Infective Endocarditis Is Associated With Injection Drug Use
por: Viehman, J Alexander, et al.
Publicado: (2018)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Adhesins in Candida glabrata
por: Timmermans, Bea, et al.
Publicado: (2018)

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
por: Amirrajab, Nasrin, et al.
Publicado: (2016)

Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy
por: Ames, Lauren, et al.
Publicado: (2017)

Antifungal Activity of a Hydroethanolic Extract From Astronium urundeuva Leaves Against Candida albicans and Candida glabrata
por: Bonifácio, Bruna Vidal, et al.
Publicado: (2019)

Genomic Assembly of Clinical Candida glabrata (Nakaseomyces glabrata) Isolates Reveals within-Species Structural Plasticity and Association with In Vitro Antifungal Susceptibility
por: Stefanini, Irene, et al.
Publicado: (2022)

752. Decreased Echinocandin Resistance among Candida glabrata over an Eleven-Year Period at a University Hospital
por: Raabe, Nathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejhi9sou7rg21ul006qttaegs0